Top Markets
Coin of the day
VectivBio Holding AG VectivBio Holding AG

VectivBio Holding AG

VECT
Peringkat dalam Saham #14766
VectivBio Holding AG is a clinical-stage biopharmaceutical firm committed to... VectivBio Holding AG is a clinical-stage biopharmaceutical firm committed to identifying, developing, and commercializing treatments for severe rare medical conditions. The company's primary therapeutic focus is apraglutide, a prolonged-acting synthetic peptide analog of glucagon-like peptide-2. This compound is currently in a Phase III clinical trial for individuals with short bowel syndrome-intestinal failure (SBS-IF), and is also being evaluated in a Phase II clinical trial for SBS-IF patients with colon-in-continuity anatomy. Furthermore, apraglutide is undergoing a Phase II clinical study for patients experiencing steroid-refractory gastrointestinal acute graft-versus-host disease (aGvHD). Founded in 2019, VectivBio's corporate headquarters are situated in Basel, Switzerland.
Harga Saham
$16.85
Terakhir disinkronkan: 2023-07-07
Kapitalisasi Pasar
$393.50M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
CH
Perdagangan VectivBio Holding AG (VECT)

Kategori

Riwayat pemecahan saham untuk VectivBio Holding AG (VECT)
Saham VectivBio Holding AG (simbol: VECT) telah mengalami total 0 kali pemecahan saham.
Pemecahan saham terbaru terjadi pada Sep 01, 2026.
Satu lembar saham VECT yang dibeli sebelum Sep 01, 2026 sekarang setara dengan 0 lembar saham VECT.
Daftar pemecahan saham
Tahun Pemecahan Kelipatan Kelipatan Kumulatif
Tidak cukup data untuk tanggal yang disediakan.
Pemecahan saham untuk perusahaan sejenis atau pesaing
Perusahaan Jumlah pemecahan saham Kelipatan Kumulatif Negara
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH